Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Niraparib & Fallopian Tube Cancer, niraparib is approved by both FDA and EMA for “advanced ovarian, fallopian tube, or primary peritoneal cancer” regardless of gBRCAm status in the maintenance setting following platinum‑based chemotherapy, depending on response and line of therapy (1).
In the NOVA trial, researchers compared the effects of niraparib with a placebo in two separate groups, categorized by the presence of a germline BRCA mutation (gBRCAm) versus those without the mutation (non-gBRCAm). The findings showed tha…